ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 203 filers reported holding ZAI LAB LTD in Q4 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $673,282 | +8.3% | 20,243 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $621,460 | -34.2% | 20,243 | -26.7% | 0.00% | -50.0% |
| Q3 2022 | $944,000 | -1.5% | 27,616 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $958,000 | -21.2% | 27,616 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,215,000 | -30.0% | 27,616 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $1,736,000 | -40.3% | 27,616 | 0.0% | 0.01% | -44.4% |
| Q3 2021 | $2,910,000 | -40.5% | 27,616 | 0.0% | 0.01% | -43.8% |
| Q2 2021 | $4,888,000 | +32.6% | 27,616 | 0.0% | 0.02% | +23.1% |
| Q1 2021 | $3,685,000 | +34.8% | 27,616 | +36.8% | 0.01% | +30.0% |
| Q4 2020 | $2,733,000 | +62.7% | 20,194 | 0.0% | 0.01% | +42.9% |
| Q3 2020 | $1,680,000 | +1.3% | 20,194 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,659,000 | +59.5% | 20,194 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $1,040,000 | – | 20,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 304,820 | $10,154 | 23.52% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $15,299,600 | 11.92% |
| Genesis Investment Management, LLP | 1,569,764 | $52,210 | 5.67% |
| Privium Fund Management B.V. | 240,683 | $8,005,117 | 2.69% |
| Segantii Capital Management Ltd | 2,278,275 | $75,775,427 | 2.66% |
| Paradigm Biocapital Advisors LP | 780,558 | $25,961,359 | 2.46% |
| HSG Holding Ltd | 694,634 | $23,103,527 | 2.43% |
| E Fund Management (Hong Kong) Co., Ltd. | 82,587 | $2,747 | 1.53% |
| INDUS CAPITAL PARTNERS, LLC | 25,256 | $840,015 | 1.29% |
| Vivo Capital, LLC | 416,640 | $13,857,446 | 0.96% |